ctrl K

Watchlist Price Alert

Elicio Therapeutics Inc. (ELTX)

NASDAQ: ELTX · Real-Time Price · USD

5.38

-0.12 (-2.18%)

At close: May 05, 2025, 3:59 PM

5.50

2.23%

Pre-market: May 06, 2025, 06:32 AM EDT

Elicio Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	28.31M	2.88M	1.49M	4.03M
Cost of Revenue	n/a	1.17M	1.06M	1.23M	1.82M	1.14M	380K
Gross Profit	n/a	-1.17M	-1.06M	27.08M	1.06M	351K	3.65M
Operating Income	-44.99M	-35.74M	-23.73M	-25.47M	-15.72M	-12.34M	-14.34M
Interest Income	777K	373K	64.83K	3.39K	8.94K	81.48K	252K
Pretax Income	-51.9M	-35.2M	-28.21M	-26.4M	-15.71M	-12.26M	-20.02M
Net Income	-51.9M	-35.2M	-28.21M	-26.4M	-15.71M	-12.26M	-20.02M
Selling & General & Admin	11.33M	11.9M	5.63M	7.54M	3M	2.8M	8.84M
Research & Development	33.66M	22.68M	18.1M	17.93M	12.72M	9.54M	9.15M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	44.99M	34.58M	23.73M	25.47M	15.72M	12.34M	17.99M
Interest Expense	-455K	1.06M	3.6M	876.44K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	35.74M	23.73M	25.47M	15.72M	12.34M	18.37M
Income Tax Expense	n/a	n/a	3.6M	876.44K	8.94K	81.48K	n/a
Shares Outstanding (Basic)	12.2M	5.06M	3.1M	3.2M	8.15M	8.15M	2.95M
Shares Outstanding (Diluted)	12.2M	5.06M	3.1M	3.2M	8.15M	8.15M	2.95M
EPS (Basic)	-4.25	-6.96	-9.1	-8.25	-1.93	-1.5	-6.79
EPS (Diluted)	-4.25	-6.96	-9.1	-8.25	-1.93	-1.5	-6.79
EBITDA	-44.99M	-32.97M	-23.55M	-51.92M	-15.53M	-40.16M	-14.34M
EBIT	-52.35M	-34.14M	-24.61M	-52.73M	-71.26M	-40.66M	-20.02M
Depreciation & Amortization	7.37M	1.17M	1.06M	801K	628K	496K	2K